Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta‐analysis
出版年份 2021 全文链接
标题
Evaluation of treatment effects in patients with endometrial cancer and
POLE
mutations: An individual patient data meta‐analysis
作者
关键词
-
出版物
CANCER
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2021-04-02
DOI
10.1002/cncr.33516
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Randomized Phase II Trial of Carboplatin–Paclitaxel Compared with Carboplatin–Paclitaxel–Trastuzumab in Advanced (Stage III–IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis
- (2020) Amanda N. Fader et al. CLINICAL CANCER RESEARCH
- POLE mutation combined with microcystic, elongated and fragmented (MELF) pattern invasion in endometrial carcinomas might be associated with poor survival in Chinese women
- (2020) Dan He et al. GYNECOLOGIC ONCOLOGY
- Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy
- (2020) Alicia León-Castillo et al. JOURNAL OF CLINICAL ONCOLOGY
- Phenotype of POLE-mutated endometrial cancer
- (2019) Sara Imboden et al. PLoS One
- Mismatch repair deficiency as a predictive marker for response to adjuvant radiotherapy in endometrial cancer
- (2019) Casper Reijnen et al. GYNECOLOGIC ONCOLOGY
- Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer
- (2019) Marina Stasenko et al. GYNECOLOGIC ONCOLOGY
- Clinicopathological and molecular characterisation of ‘multiple‐classifier’ endometrial carcinomas
- (2019) Alicia León‐Castillo et al. JOURNAL OF PATHOLOGY
- Interpretation of somatic POLE mutations in endometrial carcinoma
- (2019) Alicia León‐Castillo et al. JOURNAL OF PATHOLOGY
- Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series
- (2018) S Kommoss et al. ANNALS OF ONCOLOGY
- A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers
- (2018) Ashton C. Berger et al. CANCER CELL
- Adjuvant Treatment forPOLEProofreading Domain–Mutant Cancers: Sensitivity to Radiotherapy, Chemotherapy, and Nucleoside Analogues
- (2018) Inge C. Van Gool et al. CLINICAL CANCER RESEARCH
- Estimation of causal effect measures with the R-package stdReg
- (2018) Arvid Sjölander EUROPEAN JOURNAL OF EPIDEMIOLOGY
- The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses
- (2018) Jessica McAlpine et al. JOURNAL OF PATHOLOGY
- Refinement of high-risk endometrial cancer classification using DNA damage response biomarkers: a TransPORTEC initiative
- (2018) Aurélie Auguste et al. MODERN PATHOLOGY
- Clinical impact of endometrial cancer stratified by genetic mutational profiles, POLE mutation, and microsatellite instability
- (2018) Tomoko Haruma et al. PLoS One
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Frequent Homologous Recombination Deficiency in High-grade Endometrial Carcinomas
- (2018) Marthe M. de Jonge et al. CLINICAL CANCER RESEARCH
- Escalation and de-escalation in HER2 positive early breast cancer
- (2018) Maria Vittoria Dieci et al. CURRENT OPINION IN ONCOLOGY
- Hypermutated tumours in the era of immunotherapy: The paradigm of personalised medicine
- (2017) Laetitia Nebot-Bral et al. EUROPEAN JOURNAL OF CANCER
- Polymerase ε (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro
- (2017) Stefania Bellone et al. GYNECOLOGIC ONCOLOGY
- Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: NCI clinical trials planning meeting report on identifying key genes and molecular pathways for targeted endometrial cancer trials
- (2017) Helen J. MacKay et al. Oncotarget
- Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition
- (2017) Florine A. Eggink et al. OncoImmunology
- Endometrial Carcinomas with POLE Exonuclease Domain Mutations Have a Favorable Prognosis
- (2016) M. K. McConechy et al. CLINICAL CANCER RESEARCH
- Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts
- (2016) Ellen Stelloo et al. CLINICAL CANCER RESEARCH
- Treatment related outcomes in high-risk endometrial carcinoma: Canadian high risk endometrial cancer consortium (CHREC)
- (2016) Marcus Q. Bernardini et al. GYNECOLOGIC ONCOLOGY
- Mutation spectrum of POLE and POLD1 mutations in South East Asian women presenting with grade 3 endometrioid endometrial carcinomas
- (2016) Adele Wong et al. GYNECOLOGIC ONCOLOGY
- Prognostic Significance of POLE Exonuclease Domain Mutations in High-Grade Endometrioid Endometrial Cancer on Survival and Recurrence
- (2016) Caroline C. Billingsley et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Propensity Score-Based Approaches to Confounding by Indication in Individual Patient Data Meta-Analysis: Non-Standardized Treatment for Multidrug Resistant Tuberculosis
- (2016) Gregory J. Fox et al. PLoS One
- Meta-analysis using individual participant data: one-stage and two-stage approaches, and why they may differ
- (2016) Danielle L. Burke et al. STATISTICS IN MEDICINE
- Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma
- (2016) Yuri E. Nikiforov et al. JAMA Oncology
- A clinically applicable molecular-based classification for endometrial cancers
- (2015) A Talhouk et al. BRITISH JOURNAL OF CANCER
- Polymerase ε (POLE) ultra-mutated tumors induce robust tumor-specific CD4+ T cell responses in endometrial cancer patients
- (2015) Stefania Bellone et al. GYNECOLOGIC ONCOLOGY
- Preferred Reporting Items for a Systematic Review and Meta-analysis of Individual Participant Data
- (2015) Lesley A. Stewart et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative
- (2015) Ellen Stelloo et al. MODERN PATHOLOGY
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Polymerase ɛ (POLE) mutations in endometrial cancer: Clinical outcomes and implications for Lynch syndrome testing
- (2014) Caroline C. Billingsley et al. CANCER
- POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium
- (2014) Bo Meng et al. GYNECOLOGIC ONCOLOGY
- Prognostic Significance of POLE Proofreading Mutations in Endometrial Cancer
- (2014) David N. Church et al. JNCI-Journal of the National Cancer Institute
- Poor Interobserver Reproducibility in the Diagnosis of High-grade Endometrial Carcinoma
- (2013) C. Blake Gilks et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Assessing Bias in Studies of Prognostic Factors
- (2013) Jill A. Hayden et al. ANNALS OF INTERNAL MEDICINE
- Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2013) N. Colombo et al. ANNALS OF ONCOLOGY
- Reproducibility of histological cell type in high-grade endometrial carcinoma
- (2013) Guangming Han et al. MODERN PATHOLOGY
- Integrated genomic characterization of endometrial carcinoma
- (2013) Gad Getz et al. NATURE
- A New Criterion for Confounder Selection
- (2011) Tyler J. VanderWeele et al. BIOMETRICS
- Prognosis and Reproducibility of New and Existing Binary Grading Systems for Endometrial Carcinoma Compared to FIGO Grading in Hysterectomy Specimens
- (2011) Hui Guan et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started